Optic Neuropathy and Retinal Toxicity Secondary to Dasatinib: Case Report

Update Item Information
Identifier 20210223_nanos_posters_196
Title Optic Neuropathy and Retinal Toxicity Secondary to Dasatinib: Case Report
Creator Alvaro Mejia-Vergara, Daniela Ramirez, Katherynn Pineda-Mejia
Subject Optic Neuropathy; Retina; Chemotherapy and Radiation Injury
Description Dasatinib is a second generation of tyrosine kinase inhibitor oral chemotherapy used in chronic myeloid leukemia (CML). Although multiple adverse effects have been described, few cases have presented with neuro-ophthalmological complaints.
Date 2021-02
Language eng
Format application/pdf
Type Text
Source 2021 North American Neuro-Ophthalmology Society Annual Meeting
Relation is Part of NANOS Annual Meeting 2021: Poster Session IV: Disorders of the Anterior Visual Pathway (Retina, Optic Nerve, and Chiasm)
Collection Neuro-ophthalmology Virtual Education Library: NOVEL http://NOVEL.utah.edu
Publisher Spencer S. Eccles Health Sciences Library, University of Utah
Holding Institution North American Neuro-Ophthalmology Association. NANOS Executive Office 5841 Cedar Lake Road, Suite 204, Minneapolis, MN 55416
Rights Management Copyright 2021. For further information regarding the rights to this collection, please visit: https://NOVEL.utah.edu/about/copyright
ARK ark:/87278/s62k27jt
Context URL The NANOS Annual Meeting Neuro-Ophthalmology Collection: https://novel.utah.edu/collection/NAM/toc/
Contributor Primary Alvaro Mejia-Vergara
Contributor Secondary Daniela Ramirez, Katherynn Pineda-Mejia
Setname ehsl_novel_nam
ID 1675986
Reference URL https://collections.lib.utah.edu/ark:/87278/s62k27jt
Back to Search Results